FDA Inspection 1041913 — eNeura, Inc.
The FDA completed an inspection of eNeura, Inc. on Jan 11, 2018 in West Palm Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 11, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- West Palm Beach, FL (United States)